This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Claude Negrier: Innovator in Hemophilia Treatment
Introduction
Claude Negrier is a notable inventor based in France, recognized for his contributions to the field of hemophilia treatment. His work primarily focuses on improving variants of human Factor VIII, which plays a crucial role in blood clotting.
Latest Patents
Negrier holds a patent titled "Nouveaux Facteurs VIII Pour Le Traitement Des Hemophiles De Type A." This invention relates to enhanced variants of human FVIII that contain at least one substitution in the A2 and/or C2 domain. The application of this invention is particularly significant for treating type A hemophilia, especially in patients who have developed inhibitors.
Career Highlights
Throughout his career, Claude Negrier has worked with reputable organizations, including Biomethodes and Hospices Civils De Lyon. His experience in these institutions has contributed to his expertise in the medical field, particularly in hemophilia research and treatment.
Collaborations
Negrier has collaborated with several professionals in his field, including Didier Saboulard and Jean-Luc Plantier. These partnerships have likely enhanced his research and development efforts in hemophilia treatment.
Conclusion
Claude Negrier's innovative work in the treatment of hemophilia showcases his dedication to improving patient outcomes. His contributions to the field are significant, and his ongoing research continues to impact the lives of those affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile